Uricalm Pain Relief, Urinary, Highest Dose, Tablets 24 Ea

Other Information: Warning: This product contains a chemical known to the State of California to cause cancer. Precaution: Carcinogenesis: Long-term administration of phenazopyridine HCI has induced neoplasia in rats (large intestine) and mice (liver). Although no association between phenazopyridine HCI and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted. (Contents sealed: Contains no gluten ingredients) Contents sealed: Each URIcalm dark red colored, round shaped tablet bears the identifying mark Alva and a 1 on the reverse side, and is sealed in a clear plastic blister with foil backing. Do not use if seal appears broken or if product contents do not match product description. This product may stain soft contact lenses. This product can interfere with laboratory tests including urine, glucose (sugar) and ketones. You may report serious side effects to the phone number provided under Questions? below.